Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers

Exclusion Criteria

• •1. Subjects \< 18 years of age
• •2. Subject is non-diabetic
• •3. Subjects who present with wounds of etiology other than diabetes
• •4. Subject demonstrates increased signs of clinical infection
• •5. Has active malignant disease of any kind. A subject, who has had a malignant disease in the past, was treated and is currently disease-free, may be considered for study entry.
• •6. University of Texas Classification greater than grade 1A
• •7. Diabetic plantar foot wounds measuring \>4.0cm²
• •8. Subjects who present with significant vascular or metabolic comorbidity that would preclude wound healing
• •9. Subjects participating in any other trials in regards to the diabetic foot ulcer